[en] BACKGROUND: We investigated whether chronic headache related to medication overuse (MOH) is associated with changes in brain mechanisms regulating inhibitory cortical responses compared with healthy volunteers and episodic migraineurs recorded between attacks, and whether these changes differ according to the drug overused. SUBJECTS AND METHODS: We studied 40 MOH patients whose symptoms were related to triptans alone, non-steroidal anti-inflammatory drugs (NSAIDs) or both medications combined, 12 migraineurs and 13 healthy volunteers. We used high-intensity transcranial magnetic stimulation over the primary motor cortex to assess the silent period from contracted perioral muscles. RESULTS: In MOH patients the cortical silent period differed according to the type of headache medication overused: in patients overusing triptans alone it was shorter than in healthy volunteers (44.7 +/- 14.2 vs. 108.1 +/- 30.1 ms), but similar to that reported in migraineurs (59.9 +/- 30.4 ms), whereas in patients overusing NSAIDs alone or triptans and NSAIDs combined duration of silent period was within normal limits (80.6 +/- 46.4 and 103.8 +/- 47.2 ms). CONCLUSIONS: Compared with episodic migraineurs, MOH patients overusing triptans have no significant change in cortical inhibition, whereas those overusing NSAIDs have an increase in cortical inhibitory mechanisms. We attribute these changes to medication-induced neural adaptation promoted by changes in central serotonin neurotransmission.
Disciplines :
Neurology
Author, co-author :
Curra, Antonio
Coppola, Gianluca
Gorini, Manuela
Porretta, Elisa
Bracaglia, Martina
Di Lorenzo, Cherubino
Schoenen, Jean ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Neuro-anatomie
Pierelli, Francesco
Language :
English
Title :
Drug-induced changes in cortical inhibition in medication overuse headache.
Publication date :
2011
Journal title :
Cephalalgia
ISSN :
0333-1024
eISSN :
1468-2982
Publisher :
Blackwell Science, Osney Mead Oxford, United Kingdom
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 ; 26: 742-746
Stovner LJ, Zwart JA, Hagen K, Terwindt GM, Pascual J. Epidemiology of headache in Europe. Eur J Neurol. 2006 ; 13: 333-345
Katsarava Z, Schneeweiss S, Kurth T, Kroener U, Fritsche G, Eikermann A, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology. 2004 ; 62: 788-790 (Pubitemid 38298959)
Bigal ME, Rapoport AM, Sheftell FD, Tepper SJ, Lipton RB. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004 ; 24: 483-490 (Pubitemid 38748030)
Calabresi P, Cupini LM. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci. 2005 ; 26: 62-68 (Pubitemid 40170167)
Supornsilpchai W, le Grand SM, Srikiatkhachorn A. Cortical hyperexcitability and mechanism of medication-overuse headache. Cephalalgia. 2010 ; 30: 1101-1109
Supornsilpchai W, le Grand SM, Srikiatkhachorn A. Involvement of pro-nociceptive 5-HT2A receptor in the pathogenesis of medication-overuse headache. Headache. 2010 ; 50: 185-197
Currà A, Modugno N, Inghilleri M, Manfredi M, Hallett M, Berardelli A. Transcranial magnetic stimulation techniques in clinical investigation. Neurology. 2002 ; 59: 1851-1859 (Pubitemid 36076554)
Chen R. Studies of human motor physiology with transcranial magnetic stimulation. Muscle Nerve Suppl. 2000 ; 9: S26 - S32
Cantello R, Gianelli M, Civardi C, Mutani R. Magnetic brain stimulation: the silent period after the motor evoked potential. Neurology. 1992 ; 42: 1951-1959
Fuhr P, Agostino R, Hallett M. Spinal motor neuron excitability during the silent period after cortical stimulation. Electroencephalogr Clin Neurophysiol. 1991 ; 81: 257-262
Werhahn KJ, Kunesch E, Noachtar S, Benecke R, Classen J. Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans. J Physiol. 1999 ; 517: 591-597 (Pubitemid 29296371)
Leis AA, Kofler M, Stokic DS, Grubwieser GJ, Delapasse JS. Effect of the inhibitory phenomenon following magnetic stimulation of cortex on brainstem motor neuron excitability and on the cortical control of brainstem reflexes. Muscle Nerve. 1993 ; 16: 1351-1358 (Pubitemid 23351087)
Cruccu G, Inghilleri M, Berardelli A, Romaniello A, Manfredi M. Cortical mechanisms mediating the inhibitory period after magnetic stimulation of the facial motor area. Muscle Nerve. 1997 ; 20: 418-424 (Pubitemid 27154631)
Curra A, Pierelli F, Coppola G, Barbanti P, Buzzi MG, Galeotti F, et al. Shortened cortical silent period in facial muscles of patients with migraine. Pain. 2007 ; 132: 124-131 (Pubitemid 47494565)
Schoenen J. Deficient habituation of evoked cortical potentials in migraine: a link between brain biology, behavior and trigeminovascular activation?. Biomed Pharmacother. 1996 ; 50: 71-78 (Pubitemid 26116392)
Coppola G, Vandenheede M, Di Clemente L, Ambrosini A, Fumal A, De Pasqua V, et al. Somatosensory evoked high-frequency oscillations reflecting thalamo-cortical activity are decreased in migraine patients between attacks. Brain. 2005 ; 128: 98-103 (Pubitemid 40070524)
Cruccu G, Berardelli A, Inghilleri M, Manfredi M. Corticobulbar projections to upper and lower facial motoneurons. A study by magnetic transcranial stimulation in man. Neurosci Lett. 1990 ; 117: 68-73 (Pubitemid 20284076)
Smith MJ, Keel JC, Greenberg BD, Adams LF, Schmidt PJ, Rubinow DA, et al. Menstrual cycle effects on cortical excitability. Neurology. 1999 ; 53: 2069-2072
Werhahn KJ, Förderreuther S, Straube A. Effects of the serotonin1B/1D receptor agonist zolmitriptan on motor cortical excitability in humans. Neurology. 1998 ; 51: 896-898 (Pubitemid 28449286)
Proietti-Cecchini A, Afra J, Schoenen J. Intensity dependence of the cortical auditory evoked potentials as a surrogate marker of central nervous system serotonin transmission in man: demonstration of a central effect for the 5HT1B/1D agonist zolmitriptan (311C90, Zomig). Cephalalgia. 1997 ; 17: 849-854
Zank R, Strehl U, Larbig W, Kotchoubey B. Effects of rizatriptan on the contingent negative variation in healthy women. Cephalalgia. 2008 ; 28: 922-932
Ayzenberg I, Obermann M, Nyhuis P, Gastpar M, Limmroth V, Diener HC, et al. Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia. 2006 ; 26: 1106-1114 (Pubitemid 44199402)
Dvorzhak AY. Effects of fenamate on inhibitory postsynaptic currents in Purkinje's cells. Bull Exp Biol Med. 2008 ; 145: 564-568
Fernández M, Lao-Peregrín C, Martín ED. Flufenamic acid suppresses epileptiform activity in hippocampus by reducing excitatory synaptic transmission and neuronal excitability. Epilepsia. 2010 ; 51: 384-390
Geyer MA. Serotonergic functions in arousal and motor activity. Behav Brain Res. 1996 ; 73: 31-35 (Pubitemid 26008759)
Jacobs BL, Fornal CA. Serotonin and motor activity. Curr Opin Neurobiol. 1997 ; 7: 820-825 (Pubitemid 28052305)
Pariente J, Loubinoux I, Carel C, Albucher JF, Leger A, Manelfe C, et al. Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke. Ann Neurol. 2001 ; 50: 718-729 (Pubitemid 33116131)
Loubinoux I, Pariente J, Boulanouar K, Carel C, Manelfe C, Rascol O, et al. A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects. Neuroimage. 2002 ; 15: 26-36 (Pubitemid 34852202)
Ilic TV, Korchounov A, Ziemann U. Complex modulation of human motor cortex excitability by the specific serotonin re-uptake inhibitor sertraline. Neurosci Lett. 2002 ; 319: 116-120 (Pubitemid 34127944)
Pleger B, Schwenkreis P, Grünberg C, Malin JP, Tegenthoff M. Fluoxetine facilitates use-dependent excitability of human primary motor cortex. Clin Neurophysiol. 2004 ; 115: 2157-2163 (Pubitemid 39037305)
Gerdelat-Mas A, Loubinoux I, Tombari D, Rascol O, Chollet F, Simonetta-Moreau M. Chronic administration of selective serotonin reuptake inhibitor (SSRI) paroxetine modulates human motor cortex excitability in healthy subjects. Neuroimage. 2005 ; 27: 314-322 (Pubitemid 41074834)
Pini LA, Sandrini M, Vitale G. Involvement of brain serotonergic system in the antinociceptive action of acetylsalicylic acid in the rat. Inflamm Res. 1995 ; 44: 30-35
Sandrini M, Vitale G, Pini LA. Central antinociceptive activity of acetylsalicylic acid is modulated by brain serotonin receptor subtypes. Pharmacology. 2002 ; 65: 193-197 (Pubitemid 34765280)
Ruggieri V, Vitale G, Filaferro M, Frigeri C, Pini LA, Sandrini M. The antinociceptive effect of acetylsalicylic acid is differently affected by a CB1 agonist or antagonist and involves the serotonergic system in rats. Life Sci. 2010 ; 86: 510-517
Hoyer D, Hannon JP, Martin GR. Molecular, pharmacological and functional diversity of 5-HT receptors. Pharmacol Biochem Behav. 2002 ; 71: 533-554 (Pubitemid 34219205)
Hering R, Glover V, Pattichis K, Catarci T, Steiner TJ. 5HT in migraine patients with medication-induced headache. Cephalalgia. 1993 ; 13: 410-412 (Pubitemid 24017457)
Srikiatkhachorn A, Anthony M. Platelet serotonin in patients with analgesic-induced headache. Cephalalgia. 1996 ; 16: 423-426 (Pubitemid 26338473)
Srikiatkhachorn A, Puangniyom S, Govitrapong P. Plasticity of 5-HT serotonin receptor in patients with analgesic-induced transformed migraine. Headache. 1998 ; 38: 534-539 (Pubitemid 28429342)
Benarroch EE. Serotonergic modulation of basal ganglia circuits: complexity and therapeutic opportunities. Neurology. 2009 ; 73: 880-886
Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V. Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology. 2001 ; 57: 1694-1698 (Pubitemid 33055491)
Limmroth V, Katsarava Z, Fritsche G, Przywara S, Diener HC. Features of medication overuse headache following overuse of different acute headache drugs. Neurology. 2002 ; 59: 1011-1014
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
